REFERENCES
- Ben Smail, D., Hugeron, C., Denys, P., & Bussel B. (2006). Intrathecal baclofen for treatment of spasticity in multiple sclerosis patients. Multiple Sclerosis, 12, 101–103, doi: 10.1191/1352458506ms1232sr
- Lee, M., Reddy, H., Johansen-Berg, H., Pendlebury, S., Jenkinson, M., Smith, S., … Matthews, P. M. (2000). The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Annals of Neurology, 47, 606–613, doi:10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.0.CO;2-L
- Marra, G. A., D’Aleo, G., Di Bella, P., & Bramanti, P. (2007). Intrathecal baclofen therapy in patients with severe spasticity. Acta Neurochir Suppl, 97, 173–180, doi: 10.1007/978-3-211-33079-1_23
- Petropoulou, K. B., Panourias, I. G., Rapidi, C. A., & Sakas, D. E. (2007). The phenomenon of spasticity: a pathophysiological and clinical introduction to neuromodulation therapies. Acta Neurochirurgica Supplement, 97, 137–144, doi: 10.1007/978-3-211-33079-1_19
- Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J., Filippi, M., … Wolinsky, J. S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292–302, doi: 10.1002/ana.22366
- Reddy, H., Narayanan, S., Arnoutelis, R., Jenkinson, M., Antel, J., Matthews, P. M., & Arnold, D. L. (2000). Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain, 123, 2314–2320, doi: 10.1093/brain/123.11.2314